Skip to content

Investigation of the Use of Remote Presence Robots in Delivery of Neuromodulation

Investigation of the Use of Remote Presence Robots in the Administration of Neuromodulation Treatment

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01283633
Enrollment
30
Registered
2011-01-26
Start date
2011-02-28
Completion date
2011-08-31
Last updated
2012-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications; Neurostimulator, Satisfaction

Keywords

neuromodulation, remote presence robotics

Brief summary

In recent years, robotic devices are becoming more and more common in medical practice. Such devices provide an effective way to communicate within a clinical setting, but recent studies have shown far more diverse uses for these robots, ranging from training future surgeons to diagnoses of patients. In the investigators study, the investigators would like to investigate whether it is effective to employ robotic devices in the administration of neurostimulation treatment. It is the investigators hypothesis that the introduction of robotic devices will only yield minimal if any inaccuracies in a standard neuromodulation treatment protocol. In addition, the investigators also predict a high satisfaction rating from all participants involved in conditions involving the robot.

Detailed description

Patients with neuromodulation systems implanted for either movement disorders or chronic pain and who require programming of their systems will be approached to enter the study. Those who consent will be consecutively assigned to either the normal standard of care (i.e. programming of their systems with an experienced clinician) or programming of their systems with an inexperienced programmer (nurse) who will be directed by the experienced programmer via the remote presence robot. Both the nurses and the patients will complete questionnaires rating their satisfaction of the programming experience. They will each only receive one questionnaire at the end of the programming session. There is no other test point.

Interventions

DEVICENeuromodulation

Neuromodulation as directed via remote presence robotic and experienced clinician for those with neuromodulation systems implanted to treat movement disorders and chronic pain

Sponsors

Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with neuromodulation systems, requiring programming * nurses who have never programmed a neuromodulation system before

Exclusion criteria

* those who are unwilling to give consent

Design outcomes

Primary

MeasureTime frameDescription
Patient SatisfactionPatients will complete the questionnaire once following the neuromodulation therapy. Day 1The questionnaire will take approximately 10 minutes to complete. There are no other follow-ups required. This is the only study time commitment for the patients above the usual standard of care.

Secondary

MeasureTime frameDescription
Nursing satisfaction questionnaireImmediately following the neuromodulation session, the nurse will complete one questionnnaire. Day 1.The questionnaire will take approximately 10 minutes to complete. The time commitment from the nurse programmer will be approximately 45 minutes. There are no other test points nor follow up visits.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026